Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Quipt Home Medical ( (TSE:QIPT) ) has issued an announcement.
On March 3, 2025, Quipt Home Medical Corp. entered into a Cooperation Agreement with Kanen Wealth Management, under which Kanen agreed to withdraw its proxy solicitation notice for the 2025 annual meeting. The agreement grants Kanen certain access rights and establishes a new committee to review Kanen’s recommendations on corporate governance. This collaboration reflects Quipt’s commitment to enhancing shareholder value and executing strategic growth plans.
More about Quipt Home Medical
Quipt Home Medical Corp. is a U.S.-based provider of home medical equipment, focusing on end-to-end respiratory care. The company offers in-home monitoring and disease management services, targeting patients with chronic conditions such as heart or pulmonary disease, sleep disorders, and reduced mobility. Quipt aims to enhance shareholder value by expanding its range of services and increasing annual revenue per patient.
YTD Price Performance: -10.0%
Average Trading Volume: 27,351
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$162.9M
For detailed information about QIPT stock, go to TipRanks’ Stock Analysis page.